Literature DB >> 31010625

Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction.

Diane W Chen1, Tao Wang2, Jonathan Shey-Sen Ni3, Vlad C Sandulache1, Evan M Graboyes3, Mitchell Worley3, Joshua D Hornig3, Judith M Skoner3, Terry A Day3, Andrew T Huang4.   

Abstract

OBJECTIVE: Primary surgery followed by adjuvant therapy is the current standard of care in the multidisciplinary management of squamous cell carcinoma (SCC) of the oral tongue. Additionally, salvage glossectomy is used to treat recurrent base of tongue SCC. Microvascular free tissue transfer reconstruction (MVFTT) is utilized to maximize functional outcomes such as swallowing. We sought to identify prognostic factors related to achievement of a total oral diet in patients that underwent glossectomy with MVFTT.
METHODS: Retrospective review at a tertiary care center from 2010 to 2015.
RESULTS: 200 patients (69% male, mean age 60 years) met inclusion criteria. Extent of glossectomy was categorized as partial or hemiglossectomy (39%), tongue base resection with or without hemi-oral glossectomy (23%), composite resection with mandibulectomy (18%), and subtotal or total glossectomy (21%). Flap success rate was 96%. Median follow-up time was 14  months. A total oral diet was achieved by 49% of patients with median time to achievement of 31  days (IQR 9-209). Multivariate analysis identified body mass index  < 25 kg/m2, prior radiation therapy, adjuvant chemoradiation, and resection requiring subtotal or total glossectomy or concurrent mandibulectomy as independent risk factors for worse total oral diet achievement.
CONCLUSION: Swallowing dysfunction represents a significant morbidity following glossectomy in the treatment of SCC. High BMI, smaller resection fields, and absence of prior radiation therapy or adjuvant chemoradiotherapy correlated with improved likelihood of obtaining a total oral diet. Patients should be appropriately counseled of this risk with emphasis placed on aggressive swallow rehabilitation in the post- treatment setting.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glossectomy; Microvascular free tissue transfer; Squamous cell carcinoma; Swallowing

Mesh:

Year:  2019        PMID: 31010625      PMCID: PMC6510264          DOI: 10.1016/j.oraloncology.2019.03.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  39 in total

1.  Analysis of the relations between the shape of the reconstructed tongue and postoperative functions after subtotal or total glossectomy.

Authors:  Yoshihiro Kimata; Minoru Sakuraba; Shigeyuki Hishinuma; Satoshi Ebihara; Ryuichi Hayashi; Takahiro Asakage; Takashi Nakatsuka; Kiyonori Harii
Journal:  Laryngoscope       Date:  2003-05       Impact factor: 3.325

Review 2.  Locoregional Flaps for Oral Cavity Reconstruction: A Review of Modern Options.

Authors:  Urjeet A Patel; Gregory K Hartig; Matthew M Hanasono; Derrick T Lin; Jeremy D Richmon
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04-18       Impact factor: 3.497

Review 3.  Speech and swallowing following tongue cancer surgery and free flap reconstruction--a systematic review.

Authors:  Lisetta Lam; Nabil Samman
Journal:  Oral Oncol       Date:  2013-04-06       Impact factor: 5.337

4.  Long-term Functional Outcomes of Total Glossectomy With or Without Total Laryngectomy.

Authors:  Derrick T Lin; Bharat B Yarlagadda; Rosh K V Sethi; Allen L Feng; Yelizaveta Shnayder; Levi G Ledgerwood; Jason A Diaz; Parul Sinha; Matthew M Hanasono; Peirong Yu; Roman J Skoracki; Timothy S Lian; Urjeet A Patel; Jason Leibowitz; Nicholas Purdy; Heather Starmer; Jeremy D Richmon
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-09       Impact factor: 6.223

5.  Radiotherapy deteriorates postoperative functional outcome after partial glossectomy with free flap reconstruction.

Authors:  Yoo Seob Shin; Yoon Woo Koh; Se-Heon Kim; Jun Hui Jeong; Sanghyeon Ahn; Hyun Jun Hong; Eun Chang Choi
Journal:  J Oral Maxillofac Surg       Date:  2011-08-05       Impact factor: 1.895

6.  Ablation of advanced tongue or base of tongue cancer and reconstruction with free flap: functional outcomes.

Authors:  C Y Chien; C Y Su; C F Hwang; H C Chuang; S F Jeng; Y C Chen
Journal:  Eur J Surg Oncol       Date:  2006-02-07       Impact factor: 4.424

7.  Association of Transoral Robotic Surgery With Short-term and Long-term Outcomes and Costs of Care in Oropharyngeal Cancer Surgery.

Authors:  Kevin Motz; Hsien-Yen Chang; Harry Quon; Jeremy Richmon; David W Eisele; Christine G Gourin
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-06-01       Impact factor: 6.223

Review 8.  The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.

Authors:  Ryan Sload; Natalie Silver; Basit Abjul Jawad; Neil D Gross
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

Review 9.  Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review.

Authors:  Vinidh Paleri; Mike Drinnan; Michiel W M van den Brekel; Michael L Hinni; Patrick J Bradley; Gregory T Wolf; Remco de Bree; Johannes J Fagan; Marc Hamoir; Primož Strojan; Juan P Rodrigo; Kerry D Olsen; Phillip K Pellitteri; Ashok R Shaha; Eric M Genden; Carl E Silver; Carlos Suárez; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Laryngoscope       Date:  2014-03-11       Impact factor: 3.325

Review 10.  Total glossectomy with laryngeal preservation and free flap reconstruction: objective functional outcomes and systematic review of the literature.

Authors:  Peter T Dziegielewski; Michael L Ho; Jana Rieger; Prabhjyot Singh; Morgan Langille; Jeffrey R Harris; Hadi Seikaly
Journal:  Laryngoscope       Date:  2012-09-05       Impact factor: 3.325

View more
  1 in total

1.  Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity.

Authors:  Sagar Kansara; Tao Wang; Sina Koochakzadeh; Nelson E Liou; Evan M Graboyes; Judith M Skoner; Joshua D Hornig; Vlad C Sandulache; Terry A Day; Andrew T Huang
Journal:  Oral Oncol       Date:  2019-09-12       Impact factor: 5.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.